Levothyroxine Sodium Market

Levothyroxine Sodium is the sodium salt of levothyroxine, a synthetic levoisomer of thyroxine (T4) that is similar to the endogenous hormone produced by the thyroid gland.

Levothyroxine Sodium Market contains market size and forecasts of Levothyroxine Sodium in global, including the following market information:

• Global Levothyroxine Sodium Market Revenue, 2017-2022, 2023-2028, ($ millions)
• Global Levothyroxine Sodium Market Sales, 2017-2022, 2023-2028, (M Units)
• Global top five Levothyroxine Sodium companies in 2021 (%)

The global Levothyroxine Sodium market was valued at 3708.5 million in 2021 and is projected to reach US$ 4462.6 million by 2028, at a CAGR of 2.7% during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Oral Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of Levothyroxine Sodium include Abbvie, Mylan Pharma, Merck, Pfizer, Lannett Company, Novartis, Fresenius Kabi, IBSA and Piramal Critical Care and etc. In 2021, the global top five players have a share approximately % in terms of revenue.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Levothyroxine Sodium manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

• Global Levothyroxine Sodium Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (M Units)
• Global Levothyroxine Sodium Market Segment Percentages, by Type, 2021 (%)
• Oral
• Injection

Global Levothyroxine Sodium Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Levothyroxine Sodium Market Segment Percentages, by Application, 2021 (%)

• Hospitals
• Pharmacy
• Others

Global Levothyroxine Sodium Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (M Units)

Global Levothyroxine Sodium Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa
• Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies Levothyroxine Sodium revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies Levothyroxine Sodium revenues share in global market, 2021 (%)
• Key companies Levothyroxine Sodium sales in global market, 2017-2022 (Estimated), (M Units)
• Key companies Levothyroxine Sodium sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Abbvie
• Mylan Pharma
• Merck
• Pfizer
• Lannett Company
• Novartis
• Fresenius Kabi
• IBSA
• Piramal Critical Care
• Abbott